Affinity of cefoperazone for penicillin-binding proteins

Area of Science:

• Microbiology
• Bacterial Cell Wall Synthesis
• Antibiotic Resistance Mechanisms

Background:

• Cefoperazone (CFP) is a novel semisynthetic cephalosporin with broad-spectrum antibacterial properties.
• Understanding its mechanism of action, particularly its interaction with bacterial targets, is crucial for its effective clinical application.

Purpose of the Study:

• To investigate the binding affinity of Cefoperazone (CFP) to various penicillin-binding proteins (PBPs) in Escherichia coli and Pseudomonas aeruginosa.
• To evaluate the inhibitory effect of CFP on peptidoglycan synthesis, a critical component of bacterial cell walls.

Main Methods:

• Assessing the affinity of CFP to different PBPs in E. coli and P. aeruginosa strains.
• Measuring the inhibition of peptidoglycan synthesis, including specific enzyme activities and cross-linking processes.

Main Results:

• CFP demonstrated high affinity for specific PBPs involved in cell division in both E. coli (PBP-3, -1Bs, -2, -1A) and P. aeruginosa (PBP-3, -1A, -1B, -2, -4).
• Treatment with CFP resulted in the formation of filamentous cells, consistent with the inhibition of cell division mediated by PBP-3.
• CFP showed lower inhibition of E. coli D-alanine carboxypeptidase IA and IB compared to penicillin G, but comparable or superior inhibition of peptidoglycan cross-linking compared to penicillin G and ampicillin.

Conclusions:

• Cefoperazone's high affinity for essential PBPs, particularly those involved in cell division, explains its observed antibacterial effects.
• CFP effectively inhibits peptidoglycan synthesis, contributing to its broad-spectrum activity against Gram-negative bacteria.